Researchers use sequential FDG-PET/CT and MRI for chemo assessment

07/11/2013 | (free registration)

A study published in the Journal of Nuclear Medicine indicated that successive PET/CT and diffusion-weighed MRI may aid in monitoring and predicting response after neoadjuvant chemotherapy in patients with osteosarcoma. Researchers performed PET/CT and MRI scans on patients before and after chemotherapy and measured change in standardized uptake value and change in apparent diffusion coefficient of the bone cancer, finding the parameters were useful for predicting histologic response. The methods have also been useful in identifying suspicious lesions in patients.

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA